Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Catherine Hewison"'
Autor:
Sooyeon Kho, Kwonjune J. Seung, Helena Huerga, Mathieu Bastard, Palwasha Y. Khan, Carole D. Mitnick, Michael L. Rich, Shirajul Islam, Dali Zhizhilashvili, Lusine Yeghiazaryan, Elena Nikolaevna Nikolenko, Khin Zarli, Sana Adnan, Naseem Salahuddin, Saman Ahmed, Zully Haydee Ruíz Vargas, Amsalu Bekele, Aiman Shaimerdenova, Meseret Tamirat, Alain Gelin, Stalz Charles Vilbrun, Catherine Hewison, Uzma Khan, Molly Franke
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-7 (2024)
Abstract Sputum culture reversion after conversion is an indicator of tuberculosis (TB) treatment failure. We analyze data from the endTB multi-country prospective observational cohort (NCT03259269) to estimate the frequency (primary endpoint) among
Externí odkaz:
https://doaj.org/article/3ff129144518404289f68dc07e3488e7
Autor:
Carly A Rodriguez, Sara Lodi, C Robert Horsburgh, Carole D Mitnick, Mathieu Bastard, Helena Huerga, Uzma Khan, Michael Rich, Kwonjune J Seung, Sidney Atwood, Md Manzur-Ul-Alam, Nara Melikyan, Stephanie Mpinda, Zaw Myint, Yugandran Naidoo, Ofelya Petrosyan, Naseem Salahuddin, Samreen Sarfaraz, Stalz Charles Vilbrun, Kalkidan Yae, Jay Achar, Saman Ahmed, Elena Algozhina, Jude Beauchamp, Sara de Guadelupe Perea Moreno, Munara Gulanbaeva, Marika Gergedava, Cut Yulia Indah Sari, Catherine Hewison, Palwasha Khan, Molly F Franke
Publikováno v:
PLOS Global Public Health, Vol 3, Iss 4, p e0000818 (2023)
Clarity about the role of delamanid in longer regimens for multidrug-resistant TB is needed after discordant Phase IIb and Phase III randomized controlled trial results. The Phase IIb trial found that the addition of delamanid to a background regimen
Externí odkaz:
https://doaj.org/article/c6b18224da1245a6b31dc56b95bc2ad2
Autor:
Sekai Chenai Mathabire Rücker, Pascale Lissouba, Milcah Akinyi, Alex Vicent Lubega, Rosanna Stewart, Natalia Tamayo Antabak, Ivan Taremwa Mugisha, Liesbet Ohler, Hélder Macuácua, May Atieno, Winnie Muyindike, Stavia Turyahabwe, Gordon Odhiambo Okomo, Aleny Mahomed Couto, Mohammed Musoke, Claire Bossard, Catherine Hewison, Zibusiso Ndlovu, Helena Huerga
Publikováno v:
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, Vol 27, Iss , Pp 100316- (2022)
Background: The novel urine-based FujiLAM test identifies tuberculosis in HIV-positive patients but may be challenging to use at point-of-care (POC). Objectives: We assessed the feasibility and acceptability of using the FujiLAM test at point of care
Externí odkaz:
https://doaj.org/article/18d01999b8bf4115ac71f2f0d55fc2f3
Autor:
Uzma Khan, Helena Huerga, Aamir J. Khan, Carole D. Mitnick, Catherine Hewison, Francis Varaine, Mathieu Bastard, Michael Rich, Molly F. Franke, Sidney Atwood, Palwasha Y. Khan, Kwonjune J. Seung
Publikováno v:
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-9 (2019)
Abstract Background At a time when programs were struggling to design effective regimens for the treatment of multidrug-resistant tuberculosis (MDR-TB), the marketing authorization of bedaquiline and delamanid was a critical development in the MDR-TB
Externí odkaz:
https://doaj.org/article/5c779cd6d31044b88b3e17992de23a3a
Autor:
Lawrence Mbuagbaw, Lorenzo Guglielmetti, Catherine Hewison, Nyasha Bakare, Mathieu Bastard, Eric Caumes, Mathilde Fréchet-Jachym, Jérôme Robert, Nicolas Veziris, Naira Khachatryan, Tinatin Kotrikadze, Armen Hayrapetyan, Zaza Avaliani, Holger J. Schünemann, Christian Lienhardt
Publikováno v:
Emerging Infectious Diseases, Vol 25, Iss 5, Pp 936-943 (2019)
Bedaquiline is recommended by the World Health Organization for the treatment of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB). We pooled data from 5 cohorts of patients treated with bedaquiline in France, Georgia,
Externí odkaz:
https://doaj.org/article/aca51c7af9fb4ceb917fdc54305dfd56
Effectiveness of Bedaquiline Use Beyond Six Months in Patients with Multidrug-Resistant Tuberculosis
Autor:
Letizia Trevisi, Miguel A. Hernán, Carole Diane Mitnick, Uzma Khan, Kwonjune J Seung, Michael L. Rich, Mathieu Bastard, Helena Huerga, Nara Melikyan, Sidney Atwood, Zaza Avaliani, Felix Llanos, Mohammed Manzur-ul-Alam, Khin Zarli, Amsalu Bekele Binedgie, Sana Adnan, Arusyak Melikyan, Alain Gelin, Afshan K Isani, Dmitry Vetushko, Zhenisgul Daugarina, Patrick Nkundanyirazo, Fauziah Asnely Putri, Charles Vilbrun, Munira Khan, Catherine Hewison, Palwasha Y Khan, Molly F Franke
Publikováno v:
American Journal of Respiratory and Critical Care Medicine.
Autor:
Catherine Hewison, Uzma Khan, Mathieu Bastard, Nathalie Lachenal, Sylvine Coutisson, Elna Osso, Saman Ahmed, Palwasha Khan, Molly F Franke, Michael L Rich, Francis Varaine, Nara Melikyan, Kwonjune J Seung, Malik Adenov, Sana Adnan, Narine Danielyan, Shirajul Islam, Aleeza Janmohamed, Hayk Karakozian, Maureen Kamene Kimenye, Ohanna Kirakosyan, Begimkul Kholikulov, Aga Krisnanda, Andargachew Kumsa, Garmaly Leblanc, Leonid Lecca, Mpiti Nkuebe, Shahid Mamsa, Shrivani Padayachee, Phone Thit, Carole D Mitnick, Helena Huerga
Publikováno v:
Clinical Infectious Diseases. 75:1006-1013
Background Safety of treatment for multidrug-resistant tuberculosis (MDR/RR-TB) can be an obstacle to treatment completion. Evaluate safety of longer MDR/RR-TB regimens containing bedaquiline and/or delamanid. Methods Multicentre (16 countries), pros
Autor:
Helena Huerga, Mathieu Bastard, Alex Vicent Lubega, Milcah Akinyi, Natalia Tamayo Antabak, Liesbet Ohler, Winnie Muyindike, Ivan Mugisha Taremwa, Rosanna Stewart, Claire Bossard, Nothando Nkosi, Zibusiso Ndlovu, Catherine Hewison, Turyahabwe Stavia, Gordon Okomo, Jeremiah Okari Ogoro, Jacqueline Ngozo, Mduduzi Mbatha, Couto Aleny, Stephen Wanjala, Mohammed Musoke, Daniel Atwine, Alexandra Ascorra, Elisa Ardizzoni, Martina Casenghi, Gabriella Ferlazzo, Lydia Nakiyingi, Ankur Gupta-Wright, Maryline Bonnet
Publikováno v:
The Lancet global health
The Lancet global health, 2023, 11 (1), pp.e126-e135. ⟨10.1016/S2214-109X(22)00463-6⟩
The Lancet global health, 2023, 11 (1), pp.e126-e135. ⟨10.1016/S2214-109X(22)00463-6⟩
International audience; Background: Development of rapid biomarker-based tests that can diagnose tuberculosis using non-sputum samples is a priority for tuberculosis control. We aimed to compare the diagnostic accuracy of the novel Fujifilm SILVAMP T
Autor:
Helena Huerga, Uzma Khan, Mathieu Bastard, Carole D Mitnick, Nathalie Lachenal, Palwasha Y Khan, Kwonjune J Seung, Nara Melikyan, Saman Ahmed, Michael L Rich, Francis Varaine, Elna Osso, Makhmujan Rashitov, Naseem Salahuddin, Gocha Salia, Epifanio Sánchez, Armine Serobyan, Muhammad Rafi Siddiqui, Dri Grium Tefera, Dmitry Vetushko, Lusine Yeghiazaryan, David Holtzman, Shirajul Islam, Andargachew Kumsa, Gamarly Jacques Leblanc, Olga Leonovich, Shahid Mamsa, Mohammad Manzur-ul-Alam, Zaw Myint, Shrivani Padayachee, Molly F Franke, Catherine Hewison
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 75(8)
Background Concomitant use of bedaquiline (Bdq) and delamanid (Dlm) for multi-drug/rifampicin resistant tuberculosis (MDR/RR-TB) has raised concerns about a potentially poor risk-benefit ratio. Yet this combination is an important alternative for pat
Autor:
Kwonjune J. Seung, Molly F. Franke, Catherine Hewison, Helena Huerga, Uzma Khan, Carole D. Mitnick
Publikováno v:
Journal of Hepatology. 77:583